Filtered By:
Vaccination: Vaccines
Countries: Canada Health
This page shows you your search results in order of date. This is page number 19.
Order by Relevance | Date
Total 2706 results found since Jan 2013.
Clinical characteristics of SARS-CoV-2 vaccine-related acute appendicitis
CONCLUSION: With the exception of older age, the clinical characteristics of patients presenting with acute appendicitis within 21 days of receiving the SARS-CoV-2 vaccination did not differ from those of patients who presented with acute appendicitis not related to the vaccination. This finding suggests that vaccine-related acute appendicitis is similar to "classic" acute appendicitis.PMID:37225246 | PMC:PMC10228661 | DOI:10.1503/cjs.009322
Source: Canadian Journal of Surgery - May 24, 2023 Category: Surgery Authors: Elchanan Quint Ivan Kukeev Itai Hazan Daniel Grupel Oleg Dukhno Anton Osyntsov Gilbert Sebbag Ohad Guetta David Czeiger Source Type: research
"I Want People to Be Able to Make an Informed Choice": How Quebec naturopaths discuss vaccination in their practice
Vaccine. 2023 May 18:S0264-410X(23)00553-4. doi: 10.1016/j.vaccine.2023.05.026. Online ahead of print.ABSTRACTHealth care providers' recommendations can play an important role in individuals' vaccination decisions. Despite being one of the most popular complementary and alternative medicine (CAM), naturopathy is understudied in relation to vaccination decisions. We sought to address this gap through this study of vaccination perspectives of naturopathy practitioners in the province of Quebec, Canada. We conducted in-depth interviews with 30 naturopaths. Thematic analysis was conducted. Main themes were developed deductivel...
Source: Vaccine - May 20, 2023 Category: Allergy & Immunology Authors: Benjamin Malo Fabienne Labb é Samantha B Meyer Eric Filice Janice E Graham Noni E MacDonald Julie A Bettinger Devon Greyson Shannon E MacDonald S Michelle Driedger Gregory Kawchuk Eve Dub é Source Type: research
Inclusion of intersectionality in studies of immunization uptake in Canada: A scoping review
CONCLUSIONS: Based on our findings, there is an evident lack of intersectionality framework utilization in immunization coverage research in Canada, as well as misuse of the terms "gender" and "sex". Rather than only focusing on discrete characteristics, research should explore the interaction between numerous characteristics to better understand the barriers to immunization uptake in Canada.PMID:37202274 | DOI:10.1016/j.vaccine.2023.04.073
Source: Vaccine - May 18, 2023 Category: Allergy & Immunology Authors: Eunah Cha Vidhi Vyas Keith D King Laura Reifferscheid Shannon E MacDonald Source Type: research
Herpes zoster ophthalmicus: frequency and risk factors for developing uncommon ocular manifestations
CONCLUSIONS: The overall frequency of HZO from 2004 to 2021 was 4.2% and has increased annually since 2012. Uncommon ocular manifestations of PCR-verified HZO, mostly comprised of ARN, were more likely to occur in immunosuppressed patients.PMID:37192736 | DOI:10.1016/j.jcjo.2023.04.011
Source: Canadian Journal of Ophthalmology - May 16, 2023 Category: Opthalmology Authors: Aidan A Dmitriev Jamie Odden David Mora-Boellstorff Paul R Kinchington Kathleen Sheridan John A Viehman Danielle Price Stephen Koscumb Oscar Marroquin Jos é-Alain Sahel Regis P Kowalski Vishal Jhanji Marie-H élène Errera Source Type: research
The persistence of seroprotective levels of antibodies after vaccination with PreHevbrio, a 3-antigen hepatitis B vaccine
This study evaluated antibody persistence in a subset of fully vaccinated and seroprotected (anti-HBs ≥ 10 mIU/mL) Finnish participants from the phase 3 trial (PROTECT) of 3A-HBV versus single-antigen HBV vaccine (1A-HBV). 465/528 eligible subjects were enrolled (3A-HBV: 244; 1A-HBV: 221). Baseline characteristics were balanced. After 2.5 years, more 3A-HBV subjects remained seroprotected (88.1 % [95 %CI: 84.1,92.2]) versus 1A-HBV (72.4 % [95 %CI: 66.6,78.3)], p < 0.0001) and had higher mean anti-HBs [1382.9 mIU/mL (95 %CI: 1013.8,1751.9) versus 252.6 mIU/mL (95 %CI: 127.5,377.6), p < 0.0001]. In multiple variable ...
Source: Vaccine - May 13, 2023 Category: Allergy & Immunology Authors: T Vesikari J M Langley J N Spaans I Petrov V Popovic B Yassin-Rajkumar D E Anderson F Diaz-Mitoma Source Type: research
